Business
Tata Chemicals Q4 results: Cons loss widens YoY to Rs 2,132 crore on exceptional items; revenue drops 2%
The company reported an exceptional charge of Rs 1,837 crore is provided on account of impairment of goodwill in US & Rs 159 crore of deferred tax assets write off.
Profit after tax before exceptional items and NCI stood at Rs 279 crore compared to a loss of Rs 12 crore for Q4FY25, the company filing to the exchanges said.
The loss widened on a sequential basis too, as the company reported a net loss of Rs 93 crore in Q3FY25. The topline was down 3% on a quarter-on-quarter basis versus Rs 3,550 crore reported in the October-December quarter of FY26.
The company’s board also recommended a dividend of Rs 11 per share for the financial year 2025-26. The dividend, if approved by the members at the upcoming 87th Annual General Meeting (AGM), will be paid within five days of the AGM, the company filing said.
The company’s expenses in the quarter under review stood at Rs 3,660 crore versus Rs 3,644 crore in Q3FY26 and Rs 3,612 crore in Q4FY25. The expenses were made on heads like ‘Cost of materials consumed’, ’employee benefits expense’, finance cost and power and fuel.
The company reported a negative cash flow of Rs 1,459 crore as on March 31, 2026 ended period compared to Rs 568 crore as of March 31, 2025. The CFO was adjusted for depreciation and amortisation expenses, fianance cost and dividend income, among other things.The net profit margin in the reported quarter stood at -61.55% versus -1.94% in Q3FY25 and 1.91% in Q4FY25.
The company’s Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) stood at Rs 274 crore as compared to Rs 327 crore in Q4FY25, mainly on account of subdued pricing across all geographies and increase in fixed cost (also due to steep depreciation of Indian Rupee) as compared to Q4FY25.
Net debt (without leases) as on March 31, 2026, stood at Rs 5,961 crore.
Management commentary
R. Mukundan, Managing Director & CEO of Tata Chemicals said the global soda ash market remained oversupplied in Q4FY26, keeping prices under pressure amid geopolitical uncertainties in the Middle East. While standalone performance was supported by higher volumes and cost discipline, consolidated results were hit by weak pricing across regions, particularly in Southeast Asia, along with impairment charges in the US business.
He added that the company continues to focus on long-term growth initiatives, including the acquisition of Novabay Pte. Ltd. to expand its specialty chemicals portfolio and a Rs 100 crore investment to enhance salt capacity at Mithapur. Despite the challenging environment, Tata Chemicals remains focused on protecting margins, conserving cash flows, and maintaining a strong balance sheet to navigate the current cycle and drive sustainable value creation.
(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)
You must be logged in to post a comment Login